Fastidious anaerobe agar compared with Wilkins-Chalgren agar, brain heart infusion agar, and brucella agar for susceptibility testing of Fusobacterium species
- 1 November 1990
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 34 (11) , 2280-2282
- https://doi.org/10.1128/aac.34.11.2280
Abstract
Fastidious anaerobe agar supported the growth of 82 strains of fusobacteria better than brain heart infusion agar, brucella agar, and Wilkins-Chalgren agar. Fastidious anaerobe agar showed less hazing and fewer tailing endpoints with beta-lactam antibiotics. Whole-blood supplementation improved the performance of all media. Wilkins-Chalgren agar without blood failed to support the growth of 17% of the strains. All Fusobacterium ulcerans strains were resistant to clindamycin.This publication has 7 references indexed in Scilit:
- Cell-wall-defective variants of FusobacteriumAntimicrobial Agents and Chemotherapy, 1989
- Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis groupJournal of Clinical Microbiology, 1988
- Fusobacterium ulcerans sp. nov. from Tropical UlcersInternational Journal of Systematic and Evolutionary Microbiology, 1988
- Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitalsJournal of Clinical Microbiology, 1988
- Factors affecting antimicrobial susceptibility of Fusobacterium speciesJournal of Clinical Microbiology, 1987
- Gram-Negative Anaerobic Bacilli: Their Role in Infection and Patterns of Susceptibility to Antimicrobial Agents. II. Little-Known Fusobacterium Species and Miscellaneous GeneraClinical Infectious Diseases, 1981